Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02333110 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GRID Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 2025 to Dec 2026
    • Study completion date: Dec 2025 to Dec 2027
    v23
  2. 2 versions Re-verified since Apr 7, 2022, no change to tracked fieldsv21-v22
  3. Primary and study completion dates: Dec 2020 to Dec 2025v20
  4. Re-verified, no change to tracked fieldsv19
  5. Primary and study completion dates: Dec 2019 to Dec 2020v18
Show 16 earlier versionsHide 16 earlier versions
  1. Re-verified, no change to tracked fieldsv17
  2. Primary completion date: Dec 2018 to Dec 2019v16
  3. Site contact updatedv15
  4. Primary completion date: Dec 2017 to Dec 2018
    • Study completion date: Dec 2018 to Dec 2019
    v14
  5. Re-verified, no change to tracked fieldsv13
  6. Primary completion date: Dec 2016 to Dec 2017v12
  7. Site contact updatedv11
  8. 5 versions Re-verified since Jan 29, 2016, no change to tracked fieldsv6-v10
  9. Study completion date: Dec 2018
    • Site contact updated
    v5
  10. Re-verified, no change to tracked fieldsv4
  11. Site contact updatedv3
  12. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Feb 2015 to Jan 2015
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Palliative radiation therapy represents 40% of the on-going radiation at the Jewish General Hospital. In a traditional palliative radiation treatment to bulky or radioresistant tumors, radiotherapy schema varies from 24 to 30 Gys given in 3 to 10 fractions, depending on the tumor size, tumor location and tumor pathology. However, for many patients this treatment involves considerable toxicity, travel and time spent at the hospital. Spatially fractionated radiation (SFR) is an alternative technique that consists in delivering one single treatment, given through a grid containing holes. The present study is proposing to validate SFR as a safe and effective mean to palliate patients with symptomatic bulky tumors (more than 8 cm) or with tumors known to be resistant to radiation.
Trial Details
NCT Number NCT02333110
Lead Sponsor Sir Mortimer B. Davis - Jewish General Hospital
Conditions
(from sponsor)		 Patients With Symptomatic or Bulky Tumors (More Than 8 cm) or With Tumors Resistant to Radiation
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov